Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGER1 | P34995 | 1/20 | 0.45 |
| ▸ | PTGFR | P43088 | 1/20 | 0.45 |
| ▸ | PTGER3 | P43115 | 1/20 | 0.45 |
| ▸ | PTGER2 | P43116 | 1/20 | 0.45 |
| ▸ | HPGD | P15428 | 3/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | MMP12 | P39900 | 4/20 | 0.39 |
| ▸ | MMP13 | P45452 | 4/20 | 0.39 |
| ▸ | MMP2 | P08253 | 1/20 | 0.39 |
| ▸ | MMP9 | P14780 | 1/20 | 0.39 |
| ▸ | MMP14 | P50281 | 1/20 | 0.39 |
| ▸ | GPR84 | Q9NQS5 | 4/20 | 0.38 |
| ▸ | NPC1 | O15118 | 3/20 | 0.37 |
| ▸ | RAB9A | P51151 | 3/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | FBP1 | P09467 | 1/20 | 0.34 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3862984 | 0.91 | PTGER1 (0.44) | PTGER1PTGFRPTGER3PTGER2HPGD | |
| SCHEMBL6282249 | 0.82 | PTGER1 (0.51) | PTGER1PTGFRPTGER3PTGER2HPGD | |
| SCHEMBL4339780 | 0.79 | ALDH1A1 (0.56) | PTGER1PTGFRPTGER3PTGER2HPGD | |
| SCHEMBL3867561 | 0.77 | HPGD (0.53) | PTGER1PTGFRPTGER3PTGER2HPGD | |
| SCHEMBL6278596 | 0.76 | HPGD (0.55) | PTGER1PTGFRPTGER3PTGER2HPGD | |
| SCHEMBL5717731 | 0.75 | HPGD (0.47) | PTGER1PTGFRPTGER3PTGER2HPGD | |
| SCHEMBL5180169 | 0.75 | NPC1 (0.48) | MMP12MMP13MMP2MMP9MMP14 | |
| SCHEMBL5725708 | 0.74 | NPC1 (0.50) | MMP12MMP13MMP2MMP9MMP14 | |
| SCHEMBL3947072 | 0.73 | ALDH1A1 (0.57) | MMP12MMP13MMP2MMP9MMP14 | |
| SCHEMBL5179086 | 0.72 | HPGD (0.63) | HPGDMAPTNPC1RAB9AALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6861496-B2 | Polyhydroxyalkonoate and method of producing same, and ω-(2-thienylsulfanyl) alkanoic acid and method of producing same | CANON KABUSHIKI KAISHA (JP) | 2005-03-01 | — | — | US | disclosed |
| EP-1236754-B1 | Polyhydroxyalkanoate and method of producing the same, and omega-(2-thienylsulfanyl)alkanoic acid and method of producing the same | CANON KK (JP) | 2004-04-28 | — | — | EP | disclosed |
| US-20040062811-A1 | Polyhydroxyalkonoate and method of producing same, and w-(2-thienylsulfanyl) alkanoic acid and method of producing same | CANON KABUSHIKI KAISHA | 2004-04-01 | — | — | US | disclosed |
| US-6686439-B2 | POLYHYDROXYALKANOATE FOR USE IN CULTURING MICROORGANISMS | CANON KABUSHIKI KAISHA (JP) | 2004-02-03 | — | — | US | disclosed |
| US-20020164726-A1 | Polyhydroxyalkanoate and method of producing same, and w-(2-thienylsulfanyl) alkanoic acid and method of producing same | CANON KABUSHIKI KAISHA (JP) | 2002-11-07 | — | — | US | disclosed |
| EP-1236754-A2 | Polyhydroxyalkanoate and method of producing same, and omega-(2-thienylsulfanyl) alkanoic acid and method of producing same | CANON KABUSHIKI KAISHA (JP) | 2002-09-04 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040062811-A1 | Polyhydroxyalkonoate and method of producing same, and w-(2-thienylsulfanyl) alkanoic acid and method of producing same | HACL2, PAH, TST | PTGER1 1756/4885PTGFR 1238/4885PTGER3 2614/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.